84 related articles for article (PubMed ID: 2283896)
1. [Evaluation and significance of circulating immunocomplexes and their correlation with other immunologic parameters in connective tissue diseases].
Rodrigo MJ; Fonollosa V; Vilardell M; Codina R; Lience E; Schwartz S
Med Clin (Barc); 1990 Sep; 95(7):241-6. PubMed ID: 2283896
[TBL] [Abstract][Full Text] [Related]
2. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
[No Abstract] [Full Text] [Related]
4. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
[TBL] [Abstract][Full Text] [Related]
5. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
6. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
7. [Detection of circulating immune complexes in systemic lupus erythematosus by the method of conglutinin and monoclonal rheumatoid factor].
de Oliveira RM; Marchiori PE; Viana Vdos S; Bueno C; dos Reis M; Quevedo ME; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):6-9. PubMed ID: 4059787
[No Abstract] [Full Text] [Related]
8. Circulating immune complexes and the complements system in lupus nephropathy.
Serban MG
Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
[TBL] [Abstract][Full Text] [Related]
9. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y
Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
[No Abstract] [Full Text] [Related]
11. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
Schifferli JA; Morris SM; Dash A; Peters DK
Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
Schrieber L; Maini RN
Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
[No Abstract] [Full Text] [Related]
14. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
15. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
16. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
17. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
[TBL] [Abstract][Full Text] [Related]
18. [Antineutrophil cytoplasmic antibodies in patients with diffuse diseases of connective tissue].
Dadonene I; Redaĭtene E; Shaulauskene I; Kirdaĭte G; Vasiliauskene L
Ter Arkh; 2002; 74(5):38-43. PubMed ID: 12087904
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes in progressive systemic sclerosis and mixed connective tissue disease.
Cunningham PH; Andrews BS; Davis JS
J Rheumatol; 1980; 7(3):301-8. PubMed ID: 7401065
[TBL] [Abstract][Full Text] [Related]
20. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
